• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺铂-DNA加合物是核糖体RNA转录因子hUBF(人类上游结合因子)的分子诱饵。

Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor).

作者信息

Treiber D K, Zhai X, Jantzen H M, Essigmann J M

机构信息

Department of Chemistry, Massachusetts Institute of Technology, Cambridge 02139.

出版信息

Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5672-6. doi: 10.1073/pnas.91.12.5672.

DOI:10.1073/pnas.91.12.5672
PMID:8202546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC44058/
Abstract

The toxicity of DNA-damaging agents is widely believed to result from the formation of lesions that block polymerases or disrupt the integrity of the genome. A mechanism heretofore not addressed is that DNA damage may titrate essential DNA-binding proteins away from their natural sites of action. This report shows that the ribosomal RNA (rRNA) transcription factor hUBF (human upstream binding factor) binds with striking affinity (Kd(app) approximately 60 pM) to the intrastrand cis-Pt(NH3)2 crosslink formed by the anticancer drug cis-diamminedichloroplatinum(II) (cisplatin). When protein blots of human cell extracts are probed with cisplatin-modified DNA, 97- and 94-kDa proteins are detected, consistent with the known sites of hUBF species. A similar analysis of blots containing in vitro translated hUBF confirmed that the protein binds cisplatin adducts with high specificity. By contrast, DNA adducts of the clinically ineffective trans isomer of cisplatin, trans-diamminedichloroplatinum(II), are not recognized by hUBF. DNase I inhibition patterns of hUBF bound to a 100-base-pair DNA fragment containing a centrally located cis-Pt(NH3)2-d(GpG) crosslink reveal specific protein-DNA interactions in a 14-base-pair region flanking the adduct. The affinity of hUBF for the rRNA promoter is similar (Kd(app) approximately 18 pM) to that measured for the cisplatin adduct. In addition, we observe that the hUBF-promoter interaction is highly sensitive to the antagonistic effects of cisplatin-DNA adducts. These results suggest that a cisplatin-mediated transcription-factor-hijacking mechanisms could disrupt rRNA synthesis, which is stimulated in proliferating cells.

摘要

人们普遍认为,DNA损伤剂的毒性源于形成的损伤会阻碍聚合酶或破坏基因组的完整性。一种迄今未被探讨的机制是,DNA损伤可能会使重要的DNA结合蛋白从其天然作用位点上被滴定下来。本报告表明,核糖体RNA(rRNA)转录因子hUBF(人类上游结合因子)与抗癌药物顺二氯二氨铂(II)(顺铂)形成的链内顺式-Pt(NH3)2-d(GpG)交联具有惊人的亲和力(Kd(app)约为60 pM)。当用顺铂修饰的DNA探测人类细胞提取物的蛋白质印迹时,检测到97 kDa和94 kDa的蛋白质,这与已知的hUBF种类位点一致。对含有体外翻译的hUBF的印迹进行类似分析,证实该蛋白与顺铂加合物具有高度特异性结合。相比之下,顺铂的临床无效反式异构体反二氯二氨铂(II)的DNA加合物不被hUBF识别。与含有位于中心位置的顺式-Pt(NH3)2-d(GpG)交联的100个碱基对DNA片段结合的hUBF的DNase I抑制模式揭示了加合物两侧14个碱基对区域内特定的蛋白质-DNA相互作用。hUBF对rRNA启动子的亲和力与对顺铂加合物测得的亲和力相似(Kd(app)约为18 pM)。此外,我们观察到hUBF-启动子相互作用对顺铂-DNA加合物的拮抗作用高度敏感。这些结果表明,顺铂介导的转录因子劫持机制可能会破坏rRNA合成,而rRNA合成在增殖细胞中会受到刺激。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05e4/44058/f79cbd1e7799/pnas01134-0466-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05e4/44058/ed62a54a585e/pnas01134-0464-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05e4/44058/393384ffb4cf/pnas01134-0465-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05e4/44058/cf8b30cc1a91/pnas01134-0465-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05e4/44058/f79cbd1e7799/pnas01134-0466-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05e4/44058/ed62a54a585e/pnas01134-0464-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05e4/44058/393384ffb4cf/pnas01134-0465-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05e4/44058/cf8b30cc1a91/pnas01134-0465-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05e4/44058/f79cbd1e7799/pnas01134-0466-a.jpg

相似文献

1
Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor).顺铂-DNA加合物是核糖体RNA转录因子hUBF(人类上游结合因子)的分子诱饵。
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5672-6. doi: 10.1073/pnas.91.12.5672.
2
Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor.顺铂-DNA加合物通过劫持转录因子人类上游结合因子来抑制核糖体RNA合成。
Biochemistry. 1998 Nov 17;37(46):16307-15. doi: 10.1021/bi981708h.
3
Multiple domains of the RNA polymerase I activator hUBF interact with the TATA-binding protein complex hSL1 to mediate transcription.RNA聚合酶I激活因子hUBF的多个结构域与TATA结合蛋白复合体hSL1相互作用以介导转录。
Genes Dev. 1992 Oct;6(10):1950-63. doi: 10.1101/gad.6.10.1950.
4
Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin.对一种来自哺乳动物细胞的DNA损伤识别蛋白的特性研究,该蛋白能特异性结合抗癌药物顺铂的链内d(GpG)和d(ApG) DNA加合物。
Biochemistry. 1990 Jun 19;29(24):5872-80. doi: 10.1021/bi00476a032.
5
The RNA polymerase I transcription factor, upstream binding factor, interacts directly with the TATA box-binding protein.RNA聚合酶I转录因子,上游结合因子,直接与TATA盒结合蛋白相互作用。
J Biol Chem. 1994 Dec 2;269(48):30140-6.
6
Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG proteins.核仁转录因子hUBF含有一个与HMG蛋白具有同源性的DNA结合基序。
Nature. 1990 Apr 26;344(6269):830-6. doi: 10.1038/344830a0.
7
Cloning, expression, secondary structure characterization of HMG box 1 of hUBF from E. coli and its binding to DNA.人上游结合因子(hUBF)的高迁移率族蛋白盒1(HMG box 1)在大肠杆菌中的克隆、表达、二级结构表征及其与DNA的结合
Biochim Biophys Acta. 2002 Jul 29;1598(1-2):147-55. doi: 10.1016/s0167-4838(02)00367-9.
8
Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts.在含有位点特异性放置的顺二氯二氨铂(II)DNA加合物的模板上的复制抑制和跨损伤合成。
Biochemistry. 1992 Apr 28;31(16):3975-90. doi: 10.1021/bi00131a013.
9
Cisplatin inhibits synthesis of ribosomal RNA in vivo.顺铂在体内抑制核糖体RNA的合成。
Nucleic Acids Res. 1998 Jun 15;26(12):2831-6. doi: 10.1093/nar/26.12.2831.
10
Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins.DNA结合蛋白对顺二氯二氨铂(II)及其反式异构体的DNA链间交联的识别。
Biochemistry. 1995 Sep 26;34(38):12379-87. doi: 10.1021/bi00038a035.

引用本文的文献

1
Proteome-Wide Identification of -Methyl-2'-deoxyguanosine-Binding Proteins.全蛋白质组范围内对 N6-甲基-2'-脱氧鸟苷结合蛋白的鉴定。
Anal Chem. 2025 Jul 29;97(29):16011-16018. doi: 10.1021/acs.analchem.5c03119. Epub 2025 Jul 17.
2
APE1 condensation in nucleoli of non-cancer cells depends on rRNA transcription and forming G-quadruplex RNA structures.非癌细胞核仁中的脱嘌呤/脱嘧啶核酸内切酶1(APE1)凝聚取决于核糖体RNA(rRNA)转录并形成G-四链体RNA结构。
Nucleic Acids Res. 2025 Feb 27;53(5). doi: 10.1093/nar/gkaf168.
3
Impacts of amino acid-linked platinum(II) complexes on DNA structure.

本文引用的文献

1
Structure of the HMG box motif in the B-domain of HMG1.高迁移率族蛋白1(HMG1)B结构域中HMG盒基序的结构
EMBO J. 1993 Apr;12(4):1311-9. doi: 10.1002/j.1460-2075.1993.tb05776.x.
2
Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin.Ixr1是一种酵母蛋白,它能与铂化DNA结合并赋予对顺铂的敏感性。
Science. 1993 Jul 30;261(5121):603-5. doi: 10.1126/science.8342024.
3
Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies.49例患有24种不同类型恶性肿瘤患者队列白细胞DNA中的铂-DNA加合物。
氨基酸连接的铂(II)配合物对DNA结构的影响。
J Biol Inorg Chem. 2025 Feb;30(1):87-101. doi: 10.1007/s00775-025-02097-x. Epub 2025 Jan 24.
4
Cisplatin in Liver Cancer Therapy.顺铂在肝癌治疗中的应用。
Int J Mol Sci. 2023 Jun 29;24(13):10858. doi: 10.3390/ijms241310858.
5
Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives.重新审视临床批准的铂类衍生物的抗癌毒性。
Int J Mol Sci. 2022 Dec 6;23(23):15410. doi: 10.3390/ijms232315410.
6
Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward.靶向癌症中的核糖体生物合成:经验教训与未来方向
Cancers (Basel). 2022 Apr 24;14(9):2126. doi: 10.3390/cancers14092126.
7
Human rDNA and Cancer.人类 rDNA 与癌症。
Cells. 2021 Dec 8;10(12):3452. doi: 10.3390/cells10123452.
8
Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy.核糖体蛋白与人类疾病:分子机制与靶向治疗。
Signal Transduct Target Ther. 2021 Aug 30;6(1):323. doi: 10.1038/s41392-021-00728-8.
9
Harnessing the Nucleolar DNA Damage Response in Cancer Therapy.利用核仁 DNA 损伤反应进行癌症治疗。
Genes (Basel). 2021 Jul 28;12(8):1156. doi: 10.3390/genes12081156.
10
Early nucleolar responses differentiate mechanisms of cell death induced by oxaliplatin and cisplatin.早期核仁反应可区分奥沙利铂和顺铂诱导细胞死亡的机制。
J Biol Chem. 2021 Jan-Jun;296:100633. doi: 10.1016/j.jbc.2021.100633. Epub 2021 Apr 3.
Cancer Res. 1993 Aug 15;53(16):3694-9.
4
The SRY high-mobility-group box recognizes DNA by partial intercalation in the minor groove: a topological mechanism of sequence specificity.SRY高迁移率族盒通过部分嵌入小沟来识别DNA:一种序列特异性的拓扑机制。
Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11990-4. doi: 10.1073/pnas.90.24.11990.
5
Preferential binding of the xeroderma pigmentosum group A complementing protein to damaged DNA.着色性干皮病 A 组互补蛋白与受损 DNA 的优先结合。
Biochemistry. 1993 Nov 16;32(45):12096-104. doi: 10.1021/bi00096a021.
6
Drugs five years later. Cisplatin.五年后的药物。顺铂。
Ann Intern Med. 1984 May;100(5):704-13. doi: 10.7326/0003-4819-100-5-704.
7
DNA structural variations in the E. coli tyrT promoter.大肠杆菌tyrT启动子中的DNA结构变异
Cell. 1984 Jun;37(2):491-502. doi: 10.1016/0092-8674(84)90379-9.
8
Regulation of RNA synthesis in fibroblasts during transition from resting to growing state.成纤维细胞从静止状态转变为生长状态过程中RNA合成的调控。
Proc Natl Acad Sci U S A. 1973 Oct;70(10):2819-22. doi: 10.1073/pnas.70.10.2819.
9
cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II).顺二氯二氨合铂(II)在7名癌症患者外周血白细胞中诱导形成的DNA加合物:单次剂量顺二氯二氨合铂(II)后加合物诱导及清除的定量免疫化学检测
Cancer Res. 1987 Jun 1;47(11):3000-4.
10
Suppression of human DNA alkylation-repair defects by Escherichia coli DNA-repair genes.大肠杆菌DNA修复基因对人类DNA烷基化修复缺陷的抑制作用。
Proc Natl Acad Sci U S A. 1986 Aug;83(15):5607-10. doi: 10.1073/pnas.83.15.5607.